With a new method to syn­the­size DNA, San Diego's Mol­e­c­u­lar As­sem­blies notch­es $24M Se­ries A

5 years ago
Financing

Har­vard bil­lion­aire Tim Springer has lined up his lat­est biotech launch. And he's re­cruit­ed a star R&D ex­ec to man­age ...

5 years ago
Startups

Spon­sors should flag de­cen­tral­ized as­pects of can­cer tri­als to prep for the post-Covid era, FDA says

5 years ago
FDA+
Coronavirus

Covid-19 roundup: J&J shot re­mains on hold af­ter CDC pan­el vote

5 years ago
R&D

Glax­o­SmithK­line scraps two key mid-stage tri­als for their ICOS drug in the lat­est set­back for the field

5 years ago
R&D

An­oth­er big CRO deal has land­ed as Ther­mo Fish­er ac­quires PPD for $17.4B

5 years ago
Deals

Up­dat­ed: Al­ny­lam faces DOJ probe over On­pat­tro mar­ket­ing

5 years ago
Pharma

Ex­clu­sive in­ter­view: Pe­ter Marks on why full Covid-19 vac­cine ap­provals could be just months away

5 years ago
FDA+
Coronavirus

Janet Wood­cock on if the FDA is get­ting tougher on drug re­views: ‘I don’t think so’

5 years ago
Pharma
FDA+

Meet Bench­ling, the lat­est uni­corn seek­ing to rev­o­lu­tion­ize the way sci­en­tists do work with the help of the cloud

5 years ago
Financing

Covid-19 roundup: No­vavax shakes up lead­er­ship with two pro­mo­tions and de­par­ture of CFO; Mod­er­na, No­vavax shots added ...

5 years ago
Coronavirus

Amy­lyx to move for­ward with ALS pro­gram in Eu­rope, but FDA wants an­oth­er look; Hu­ma­cyte adds $50M in debt fi­nanc­ing

5 years ago
News Briefing

The right to vote is fun­da­men­tal — a let­ter from biotech­nol­o­gy in­dus­try lead­ers

5 years ago
People
Biotech Voices

Launched by MIT grads, a small start­up gets $20M to back a ro­bot­ics rev­o­lu­tion in cell ther­a­py man­u­fac­tur­ing

5 years ago
Startups
Manufacturing

Near­ly a year af­ter Au­den­tes' gene ther­a­py deaths, the tri­al con­tin­ues. What hap­pened re­mains a mys­tery

5 years ago
Cell/Gene Tx
In Focus

It takes two to Tan­go: The biotech us­ing CRISPR to dis­cov­er new can­cer gene tar­gets rides a $353M SPAC deal to Nas­daq

5 years ago
Financing

An­ti-ag­ing biotech up­start plucks a drug from Am­gen's dis­card pile, piv­ot­ing from heart fail­ure to mus­cle con­di­tions

5 years ago
Deals

For­mer head of FDA’s med­ical and sci­en­tif­ic af­fairs on Covid: ‘FDA has nev­er been test­ed like this’

5 years ago
People
FDA+

Eli Lil­ly seeds a well-con­nect­ed Chi­na neu­ro start­up with drugs aim­ing at where Bio­gen, Voy­ager missed

5 years ago
Deals
China

'Learned a lot last year': Af­ter Covid-19 suc­cess, Mod­er­na's Stéphane Ban­cel plans to give rest of pipeline a big ...

5 years ago
R&D

Af­ter be­ing goad­ed to sell the com­pa­ny, Alex­ion's CEO set some am­bi­tious new goals for in­vestors. Then Pas­cal So­ri­ot ...

5 years ago
Deals

Mod­er­na says Covid-19 boost­ers stand a fight­ing chance against new vari­ants

5 years ago
R&D
Coronavirus

Pankaj Bhar­ga­va was a cen­tral fig­ure in the group fash­ion­ing Gilead’s on­col­o­gy strat­e­gy. Now he’s jumped to the ...

5 years ago
People

Fifth Cir­cuit sides with FTC in ma­jor pay-for-de­lay set­tle­ment case

5 years ago
Pharma
FDA+
First page Previous page 717718719720721722723 Next page Last page
A service from the Financial Times